Duopharma Biotech Secures Six-Month Extension of Government Supply Contracts

MT Newswires Live13:43

Duopharma Biotech (KLSE:DPHARMA) has received a six-month extension for its supply contracts with Pharmaniaga Logistics under the Ministry of Health for products under the approved purchase list, according to a Friday filing to the Malaysian stock exchange.

The company's shares were down nearly 1% in recent trade.

The contracts, which cover the supply of 97 products, have been extended from Jan. 1, 2027 to June 30, 2027, or such other date as may be determined by the Government of Malaysia. The existing contracts were originally set to expire on Dec. 31, 2026.

The company's wholly-owned subsidiaries Duopharma (M), Duopharma Manufacturing (Bangi) and Duopharma HAPI received notices of extension from Pharmaniaga Logistics for their respective supply agreements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment